SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-070597
Filing Date
2022-11-09
Accepted
2022-11-09 16:06:17
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_virpaxpharma.htm   iXBRL 10-Q 568730
2 CERTIFICATION f10q0922ex31-1_virpaxpharma.htm EX-31.1 9762
3 CERTIFICATION f10q0922ex31-2_virpaxpharma.htm EX-31.2 9712
4 CERTIFICATIONS f10q0922ex32-1_virpaxpharma.htm EX-32.1 5903
  Complete submission text file 0001213900-22-070597.txt   3228584

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vrpx-20220930.xsd EX-101.SCH 35843
6 XBRL CALCULATION FILE vrpx-20220930_cal.xml EX-101.CAL 16909
7 XBRL DEFINITION FILE vrpx-20220930_def.xml EX-101.DEF 161547
8 XBRL LABEL FILE vrpx-20220930_lab.xml EX-101.LAB 339735
9 XBRL PRESENTATION FILE vrpx-20220930_pre.xml EX-101.PRE 173050
45 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_virpaxpharma_htm.xml XML 305746
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40064 | Film No.: 221372531
SIC: 2834 Pharmaceutical Preparations